Published in Adv Healthc Mater on December 16, 2014
A review on powder-based additive manufacturing for tissue engineering: selective laser sintering and inkjet 3D printing. Sci Technol Adv Mater (2015) 0.80
Integration of 3D Printed and Micropatterned Polycaprolactone Scaffolds for Guidance of Oriented Collagenous Tissue Formation In Vivo. Adv Healthc Mater (2016) 0.78
Three dimensional printing of calcium sulfate and mesoporous bioactive glass scaffolds for improving bone regeneration in vitro and in vivo. Sci Rep (2017) 0.75
Highly porous scaffolds of PEDOT:PSS for bone tissue engineering. Acta Biomater (2017) 0.75
Layer-by-layer bioassembly of cellularized polylactic acid porous membranes for bone tissue engineering. J Mater Sci Mater Med (2017) 0.75
Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials (2005) 2.66
Biological implications of polydimethylsiloxane-based microfluidic cell culture. Lab Chip (2009) 2.59
Bioresorbable airway splint created with a three-dimensional printer. N Engl J Med (2013) 2.31
Moving from static to dynamic complexity in hydrogel design. Nat Commun (2012) 1.40
An approach to modulate degradation and mesenchymal stem cell behavior in poly(ethylene glycol) networks. Biomacromolecules (2008) 1.34
Non-invasive monitoring of tissue scaffold degradation using ultrasound elasticity imaging. Acta Biomater (2008) 1.29
Developing consistently reproducible intervertebral disc degeneration at rat caudal spine by using needle puncture. J Neurosurg Spine (2009) 1.28
Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials (2002) 1.26
Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev (2011) 1.25
Nondestructive micro-computed tomography for biological imaging and quantification of scaffold-bone interaction in vivo. Biomaterials (2007) 1.24
Quantitative molecular sensing in biological tissues: an approach to non-invasive optical characterization. Opt Express (2006) 1.24
A novel method for biomaterial scaffold internal architecture design to match bone elastic properties with desired porosity. J Biomech (2004) 1.20
Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater (2009) 1.19
Controlled nucleation of hydroxyapatite on alginate scaffolds for stem cell-based bone tissue engineering. J Biomed Mater Res A (2010) 1.18
Osteocyte lacuna size and shape in women with and without osteoporotic fracture. J Biomech (2004) 1.18
Controllable mineral coatings on PCL scaffolds as carriers for growth factor release. Biomaterials (2011) 1.17
Triggered drug release from dynamic microspheres via a protein conformational change. Macromol Biosci (2010) 1.16
Biomaterials that regulate growth factor activity via bioinspired interactions. Adv Funct Mater (2011) 1.16
Tissue engineering bone-ligament complexes using fiber-guiding scaffolds. Biomaterials (2011) 1.12
Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng Part A (2009) 1.12
Harnessing endogenous growth factor activity modulates stem cell behavior. Integr Biol (Camb) (2011) 1.09
Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Eng (2004) 1.07
Tailoring the mechanical properties of 3D-designed poly(glycerol sebacate) scaffolds for cartilage applications. J Biomed Mater Res A (2010) 1.07
Mineral coatings for temporally controlled delivery of multiple proteins. Adv Mater (2011) 1.06
The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J Biomed Mater Res A (2010) 1.05
An adaptable hydrogel array format for 3-dimensional cell culture and analysis. Biomaterials (2008) 1.05
Anatomic considerations of transclavicular-transcoracoid drilling for coracoclavicular ligament reconstruction. J Shoulder Elbow Surg (2012) 1.05
Using "click" chemistry to prepare SAM substrates to study stem cell adhesion. Langmuir (2009) 1.04
Biomimetic hybrid scaffolds for engineering human tooth-ligament interfaces. Biomaterials (2010) 1.03
Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther (2004) 1.02
Modular peptide growth factors for substrate-mediated stem cell differentiation. Angew Chem Int Ed Engl (2009) 1.02
Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres. Biomaterials (2012) 1.02
Immobilization of peptides with distinct biological activities onto stem cell culture substrates using orthogonal chemistries. Langmuir (2010) 1.02
Image-based, fiber guiding scaffolds: a platform for regenerating tissue interfaces. Tissue Eng Part C Methods (2013) 1.02
A modular, hydroxyapatite-binding version of vascular endothelial growth factor. Adv Mater (2010) 1.01
Framework for optimal design of porous scaffold microstructure by computational simulation of bone regeneration. Biomaterials (2006) 1.01
Influence of hydroxyapatite-coated and growth factor-releasing interference screws on tendon-bone healing in an ovine model. Arthroscopy (2009) 1.01
Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering. Biomaterials (2005) 1.01
Differential effects of designed scaffold permeability on chondrogenesis by chondrocytes and bone marrow stromal cells. Biomaterials (2009) 1.00
Surfaces that sequester serum-borne heparin amplify growth factor activity. Adv Mater (2011) 1.00
Patterning discrete stem cell culture environments via localized self-assembled monolayer replacement. Langmuir (2009) 0.99
The interaction between bone marrow stromal cells and RGD-modified three-dimensional porous polycaprolactone scaffolds. Biomaterials (2009) 0.99
Stress analysis of the interface between cervical vertebrae end plates and the Bryan, Prestige LP, and ProDisc-C cervical disc prostheses: an in vivo image-based finite element study. Spine (Phila Pa 1976) (2009) 0.99
Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells. Stem Cell Rev (2015) 0.98
Time course investigation of intervertebral disc degeneration produced by needle-stab injury of the rat caudal spine: laboratory investigation. J Neurosurg Spine (2011) 0.97
Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling. J Am Chem Soc (2012) 0.95
Retracted Immunoisolating pancreatic islets by encapsulation with selective withdrawal. Small (2007) 0.94
A comparison of the influence of material on in vitro cartilage tissue engineering with PCL, PGS, and POC 3D scaffold architecture seeded with chondrocytes. Biomaterials (2010) 0.94
Growth of hydroxyapatite coatings on biodegradable polymer microspheres. ACS Appl Mater Interfaces (2009) 0.94
Poly(epsilon-caprolactone) and poly (L-lactic-co-glycolic acid) degradable polymer sponges attenuate astrocyte response and lesion growth in acute traumatic brain injury. Tissue Eng (2007) 0.93
Substrates for cell adhesion prepared via active site-directed immobilization of a protein domain. Langmuir (2004) 0.93
Sustained plasmid DNA release from dissolving mineral coatings. Acta Biomater (2010) 0.93
Differential effects of a soluble or immobilized VEGFR-binding peptide. Integr Biol (Camb) (2012) 0.93
Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells. Tissue Eng Part A (2010) 0.91
Coating with a modular bone morphogenetic peptide promotes healing of a bone-implant gap in an ovine model. PLoS One (2012) 0.91
Interleukin expression after injury and the effects of interleukin-1 receptor antagonist. PLoS One (2013) 0.90
Macro-architectures in spinal cord scaffold implants influence regeneration. J Neurotrauma (2008) 0.90
Effect of polycaprolactone scaffold permeability on bone regeneration in vivo. Tissue Eng Part A (2011) 0.89
Influence of FGF2 and PEG hydrogel matrix properties on hMSC viability and spreading. J Biomed Mater Res A (2010) 0.89
Patterned self-assembled monolayers: efficient, chemically defined tools for cell biology. Chembiochem (2012) 0.88
Mineral coatings modulate β-TCP stability and enable growth factor binding and release. Acta Biomater (2011) 0.88
Interleukin-1 receptor antagonist modulates inflammation and scarring after ligament injury. Connect Tissue Res (2014) 0.87
Mechanical, permeability, and degradation properties of 3D designed poly(1,8 octanediol-co-citrate) scaffolds for soft tissue engineering. J Biomed Mater Res B Appl Biomater (2010) 0.87
A chemically-defined screening platform reveals behavioral similarities between primary human mesenchymal stem cells and endothelial cells. Integr Biol (Camb) (2012) 0.87
Acoustic microscopy analyses to determine good vs. failed tissue engineered oral mucosa under normal or thermally stressed culture conditions. Ann Biomed Eng (2010) 0.87
Inorganic coatings for optimized non-viral transfection of stem cells. Sci Rep (2013) 0.87
Design of growth factor sequestering biomaterials. Chem Commun (Camb) (2014) 0.87
Mechanical and biochemical assessments of three-dimensional poly(1,8-octanediol-co-citrate) scaffold pore shape and permeability effects on in vitro chondrogenesis using primary chondrocytes. Tissue Eng Part A (2010) 0.86
Facile formation of dynamic hydrogel microspheres for triggered growth factor delivery. Acta Biomater (2010) 0.86
Analysis of load sharing on uncovertebral and facet joints at the C5-6 level with implantation of the Bryan, Prestige LP, or ProDisc-C cervical disc prosthesis: an in vivo image-based finite element study. Neurosurg Focus (2010) 0.85
Controllable Soluble Protein Concentration Gradients in Hydrogel Networks. Adv Funct Mater (2008) 0.85
Hydrogels with well-defined peptide-hydrogel spacing and concentration: impact on epithelial cell behavior(). Soft Matter (2011) 0.85
The use of reactive polymer coatings to facilitate gene delivery from poly (epsilon-caprolactone) scaffolds. Biomaterials (2009) 0.85
Comparison of scanning acoustic microscopy and histology images in characterizing surface irregularities among engineered human oral mucosal tissues. Ultrasound Med Biol (2011) 0.85
Experimental and computational characterization of designed and fabricated 50:50 PLGA porous scaffolds for human trabecular bone applications. J Mater Sci Mater Med (2010) 0.85
Tissue-engineered heart valve prostheses: 'state of the heart'. Regen Med (2008) 0.84
High affinity binding of an engineered, modular peptide to bone tissue. Mol Pharm (2013) 0.84
Regulating specific growth factor signaling using immobilized branched ligands. Adv Healthc Mater (2012) 0.84
Screening the cellular microenvironment: a role for microfluidics. IEEE Rev Biomed Eng (2008) 0.84
Functionalizing calcium phosphate biomaterials with antibacterial silver particles. Adv Mater (2012) 0.84
Intradiscal injection of simvastatin retards progression of intervertebral disc degeneration induced by stab injury. Arthritis Res Ther (2009) 0.83
Biomimetic approaches to control soluble concentration gradients in biomaterials. Macromol Biosci (2011) 0.83
Poly(glycerol-dodecanoate), a biodegradable polyester for medical devices and tissue engineering scaffolds. Biomaterials (2009) 0.83
Porous biodegradable lumbar interbody fusion cage design and fabrication using integrated global-local topology optimization with laser sintering. J Biomech Eng (2013) 0.83
Multifunctional mixed SAMs that promote both cell adhesion and noncovalent DNA immobilization. Langmuir (2008) 0.82
Use of micro-computed tomography to nondestructively characterize biomineral coatings on solid freeform fabricated poly (L-lactic acid) and poly ((ε-caprolactone) scaffolds in vitro and in vivo. Tissue Eng Part C Methods (2013) 0.81
Non-linear stress-strain measurements of ex vivo produced oral mucosal equivalent (EVPOME) compared to normal oral mucosal and skin tissue. Conf Proc IEEE Eng Med Biol Soc (2011) 0.81
Engineering the emergence of stem cell therapeutics. Sci Transl Med (2013) 0.81
Specific VEGF sequestering to biomaterials: influence of serum stability. Acta Biomater (2013) 0.81
Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity. Tissue Eng Part A (2013) 0.81
Combinatorial screening of chemically defined human mesenchymal stem cell culture substrates. J Mater Chem (2012) 0.81
Characterizing morphology and nonlinear elastic properties of normal and thermally stressed engineered oral mucosal tissues using scanning acoustic microscopy. Tissue Eng Part C Methods (2012) 0.81
Effects of pseudowollastonite (CaSiO3) bioceramic on in vitro activity of human mesenchymal stem cells. Biomaterials (2010) 0.81